Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators-Reference-Cited by-同舟云学术

Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators

Published:2020-12 Issue: Volume: Page:
ISSN:1526-0542
Container-title:Paediatric Respiratory Reviews
language:en
Short-container-title:Paediatric Respiratory Reviews

Author:

Konrad Julia,Eber Ernst^ORCID,Stadlbauer Vanessa^ORCID

Funder

Medizinische Universität Graz

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference101 articles.

1. Patterns of GI disease in adulthood associated with mutations in the CFTR gene;Wilschanski;Gut,2007

2. Cystic fibrosis survival: the changing epidemiology;Corriveau;Curr Opin Pulm Med,2018

3. Cystic fibrosis;Elborn;Lancet,2016

4. CFTR modulator therapies – Effect on life expectancy in people with cystic fibrosis;Balfour-Lynn;Paediatr Respir Rev,2020

5. Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease;Shteinberg;Eur Respir Rev,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of the dietetic and MDT management of Cystic Fibrosis;UCC Student Medical Journal;2024-09-04

2. Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis;Diagnostics;2024-01-22

3. Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis;Frontline Gastroenterology;2024-01-06

4. Exocrine Pancreatic Insufficiency in Children – Challenges in Management;Pediatric Health, Medicine and Therapeutics;2023-10

5. The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis;Heliyon;2023-09